BioNxt Solutions Completes Key Funding Milestone
Company Announcements

BioNxt Solutions Completes Key Funding Milestone

BioNxt Solutions (TSE:BNXT) has released an update.

BioNxt Solutions Inc. has successfully completed the second tranche of its non-brokered private placement, issuing 1,000,000 common shares at $0.27 each for a total of $270,000. This brings them closer to their maximum goal of $1,620,000 from the sale of 6,000,000 shares. The funds raised are earmarked for research and development, commercialization programs, and general working capital.

For further insights into TSE:BNXT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBioNxt Advances MS Drug with German Pharma Partnership
TipRanks Canadian Auto-Generated NewsdeskBioNxt Solutions Extends Expiry of Warrants
TipRanks Canadian Auto-Generated NewsdeskBioNxt Solutions Advances MS Drug Development
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!